As a result of the deal, valued at over USD $65 million, Horizon will make its first move into direct manufacturing. The transaction will also see a number of EirGen’s employees transfer to Horizon, and the creation of a further 50 new roles over the next 18 months.
A cross-departmental Matheson team worked on the transaction, including Corporate M&A partner David Fitzgibbon, Commercial Real Estate partner Sally Anne Stone and Corporate M&A Partner, John Coary.
As a result of the acquisition, Horizon will acquire the 44,000 square foot EirGen manufacturing facility. The transaction is a significant boost to the Life Science ecosystem in the South East.